Pharmacology of COVID-19.

Sureda, Antoni; Habtemariam, Solomon; Nabavi, Seyed M

Sureda, Antoni; Habtemariam, Solomon; Nabavi, Seyed M.

Sureda A; Research Group in Community Nutrition and Oxidative Stress and Health Research Institute of the Balearic Islands (IdISBa), University of Balearic Islands-IUNICS, Palma de Mallorca, Spain; CIBEROBN (Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: antoni.sureda@uib.es.
Habtemariam S; Pharmacognosy Research Laboratories & Herbal Analysis Services UK, University of Greenwich, Central Avenue, Charham-Maritime, Kent, ME4 4TB, UK.
Nabavi SM; Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Chem Biol Interact ; 362: 110005, 2022 08 01.

Article in English | MEDLINE | ID: covidwho-1982675

Subject(s)

COVID-19 Drug Treatment; Antiviral Agents/pharmacology; Antiviral Agents/therapeutic use; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Limits: Humans Language: English Journal: Chem Biol Interact Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google